secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2026-07-31T21:17:23+00:00
Accession:  0001104659-26-089293
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

NW Bio enters $4.9M convertible note financing with Yorkville; also secures $50M standby equity facility
--------------------------------------------------------------------------------

- $4.9M convertible promissory note, 12-month term, no interest, 5% OID, convertible at discount to market.
- Yorkville also acquired warrant to purchase up to $2M shares at $0.205 per share.
- Standby equity subscription agreement for up to $50M in common shares, available after note repaid/converted, 24-month term.
- Proceeds for general corporate purposes including lead product and in-licensed portfolios.
- Prior standby equity subscription agreement cancelled.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465926089293/0001104659-26-089293-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465926089293/tm2620800d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-089293

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer